PubMed (GeneRIF) for id: 79633

Year	Number of Results
2009	1
2010	2
2011	1
2012	1
2013	4
2014	2
2015	3
2016	4
2017	2
2018	1
2019	4
2020	2
2021	1
2022	2
2023	5
2024	0

1

FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.

Huang FY, Wong DK, Mak LY, Cheung TT, Zhang SS, Chau HT, Hui RW, Seto WK, Yuen MF. Huang FY, et al. Hepatol Commun. 2023 Dec 7;7(12):e0338. doi: 10.1097/HC9.0000000000000338. eCollection 2023 Dec 1. Hepatol Commun. 2023. PMID: 38055646 Free PMC article.

2

Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study.

Ibrahim HM, Abdelrahman AE, Elwan A, Bakry A, Fahmy MM, Abdelhamid MI, Abdelwanis AH, Fouad EM. Ibrahim HM, et al. Appl Immunohistochem Mol Morphol. 2023 Nov-Dec 01;31(10):673-681. doi: 10.1097/PAI.0000000000001157. Epub 2023 Sep 26. Appl Immunohistochem Mol Morphol. 2023. PMID: 37751246

3

Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis.

Lv L, Qi X, Wang C, Ma Y, Nie Y, Abulaiti R, Zhang F, Shi Q, Kou Z, Abuduer M, Zhai S, An L, Huang Q, Gu Z, Ou Q, Liu H, Wang Z, Shao Y, Sun Z, Fu L, Wang X, Mao M, Li Y. Lv L, et al. Clin Exp Med. 2023 Oct;23(6):2675-2685. doi: 10.1007/s10238-023-01018-z. Epub 2023 Feb 22. Clin Exp Med. 2023. PMID: 36811800 Free PMC article.

4

Structure of the planar cell polarity cadherins Fat4 and Dachsous1.

Medina E, Easa Y, Lester DK, Lau EK, Sprinzak D, Luca VC. Medina E, et al. Nat Commun. 2023 Feb 16;14(1):891. doi: 10.1038/s41467-023-36435-x. Nat Commun. 2023. PMID: 36797229 Free PMC article.

5

A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.

Mao W, Zhou J, Hu J, Zhao K, Fu Z, Wang J, Mao K. Mao W, et al. Front Public Health. 2022 Aug 16;10:969070. doi: 10.3389/fpubh.2022.969070. eCollection 2022. Front Public Health. 2022. PMID: 36051999 Free PMC article.

6

Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltration.

Ning Y, Yang Y, Zheng H, Zhan Y, Zang H, Wen Q, Peng J, Fan S. Ning Y, et al. Cancer Med. 2023 Jan;12(2):1616-1629. doi: 10.1002/cam4.4977. Epub 2022 Jun 30. Cancer Med. 2023. PMID: 35770846 Free PMC article.

7

FAT4 identified as a potential modifier of orofacial cleft laterality.

Curtis SW, Chang D, Sun MR, Epstein MP, Murray JC, Feingold E, Beaty TH, Weinberg SM, Marazita ML, Lipinski RJ, Carlson JC, Leslie EJ. Curtis SW, et al. Genet Epidemiol. 2021 Oct;45(7):721-735. doi: 10.1002/gepi.22420. Epub 2021 Jun 15. Genet Epidemiol. 2021. PMID: 34130359 Free PMC article.

8

MiR-106b-5p regulates the migration and invasion of colorectal cancer cells by targeting FAT4.

Pan M, Chen Q, Lu Y, Wei F, Chen C, Tang G, Huang H. Pan M, et al. Biosci Rep. 2020 Nov 27;40(11):BSR20200098. doi: 10.1042/BSR20200098. Biosci Rep. 2020. PMID: 33063118 Free PMC article.

9

FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.

Malgundkar SH, Burney I, Al Moundhri M, Al Kalbani M, Lakhtakia R, Okamoto A, Tamimi Y. Malgundkar SH, et al. BMC Cancer. 2020 May 4;20(1):374. doi: 10.1186/s12885-020-06900-7. BMC Cancer. 2020. PMID: 32366234 Free PMC article.

10

Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.

Huang FY, Wong DK, Tsui VW, Seto WK, Mak LY, Cheung TT, Lai KK, Yuen MF. Huang FY, et al. BMC Cancer. 2019 Aug 8;19(1):789. doi: 10.1186/s12885-019-6002-9. BMC Cancer. 2019. PMID: 31395065 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year